FDA Adverse Event Injury Summary report: N

OXFORD CEMENTLESS TIBIA D LM

MDR report key: 14730871 · Received June 17, 2022

Report

Report Number
3002806535-2022-00281
Event Type
Injury
Date Received
June 17, 2022
Date of Event
May 10, 2022
Report Date
July 1, 2022
Manufacturer
BIOMET UK LTD.
Product Code
NRA
UDI-DI
05019279474486
PMA / PMN Number
N/A
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

(B)(4). CONCOMITANT MEDICAL PRODUCTS: OXF TWIN PEG CMNTLS FMRL MD ITEM# 161474, LOT# 3050585, OXF ANAT BRG LT MD SIZE 3 PMA MED SZ 3 ITEM# 159547, LOT# 825760. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 3002806535 - 2022 - 00279, 3002806535 - 2022 ¿ 00280.

Additional Manufacturer Narrative · 0

(B)(4). THE DEVICE HISTORY RECORDS FOR ITEM # US166576 LOT # 3050478 WERE REVIEWED FOR DEVIATIONS AND / OR ANOMALIES WITH THE FOLLOWING ANOMALIES / DEVIATIONS. ROOT CAUSE OF THE REPORTED EVENT COULD NOT BE DETERMINED EVENT. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED IN A CLINICAL STUDY THAT THE PATIENT DEVELOPED PAINFUL PES ANSERINUS BURSA ON THE LEFT KNEE APPROXIMATELY SEVEN YEARS POST-IMPLANTATION. PATIENT IS BEING TREATED WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS. NO REVISION OR FURTHER OUTCOME REPORTED. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

Description of Event or Problem · 0

NO FURTHER EVENT INFORMATION AVAILABLE AT THE TIME OF THIS REPORT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1736943 OXFORD CEMENTLESS TIBIA D LM KNEE ARTHROPLASTY NRA BIOMET UK LTD. N/A 3050478 05019279474486

Patients

Seq Age Sex Outcome Treatment
1 83 YR Male Required Intervention